Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biol Open ; 12(10)2023 10 15.
Artigo em Inglês | MEDLINE | ID: mdl-37855382

RESUMO

The developing brain has a well-organized anatomical structure comprising different types of neural and non-neural cells. Stem cells, progenitors and newborn neurons tightly interact with their neighbouring cells and tissue microenvironment, and this intricate interplay ultimately shapes the output of neurogenesis. Given the relevance of spatial cues during brain development, we acknowledge the necessity for a spatial transcriptomics map accessible to the neurodevelopmental community. To fulfil this need, we generated spatially resolved RNA sequencing (RNAseq) data from embryonic day 13.5 mouse brain sections immunostained for mitotic active neural and vascular cells. Unsupervised clustering defined specific cell type populations of diverse lineages and differentiation states. Differential expression analysis revealed unique transcriptional signatures across specific brain areas, uncovering novel features inherent to particular anatomical domains. Finally, we integrated existing single-cell RNAseq datasets into our spatial transcriptomics map, adding tissue context to single-cell RNAseq data. In summary, we provide a valuable tool that enables the exploration and discovery of unforeseen molecular players involved in neurogenesis, particularly in the crosstalk between different cell types.


Assuntos
Neurogênese , Transcriptoma , Animais , Camundongos , Neurogênese/genética , Diferenciação Celular/genética , Neurônios/metabolismo , Encéfalo/metabolismo
2.
Cell Death Dis ; 14(4): 296, 2023 04 29.
Artigo em Inglês | MEDLINE | ID: mdl-37120445

RESUMO

The diffuse nature of Glioblastoma (GBM) tumors poses a challenge to current therapeutic options. We have previously shown that Acyl-CoA Binding Protein (ACBP, also known as DBI) regulates lipid metabolism in GBM cells, favoring fatty acid oxidation (FAO). Here we show that ACBP downregulation results in wide transcriptional changes affecting invasion-related genes. In vivo experiments using patient-derived xenografts combined with in vitro models demonstrated that ACBP sustains GBM invasion via binding to fatty acyl-CoAs. Blocking FAO mimics ACBPKD-induced immobility, a cellular phenotype that can be rescued by increasing FAO rates. Further investigation into ACBP-downstream pathways served to identify Integrin beta-1, a gene downregulated upon inhibition of either ACBP expression or FAO rates, as a mediator for ACBP's role in GBM invasion. Altogether, our findings highlight a role for FAO in GBM invasion and reveal ACBP as a therapeutic vulnerability to stall FAO and subsequent cell invasion in GBM tumors.


Assuntos
Proteínas de Transporte , Glioblastoma , Humanos , Proteínas de Transporte/metabolismo , Glioblastoma/genética , Inibidor da Ligação a Diazepam/metabolismo , Metabolismo dos Lipídeos , Ácidos Graxos/metabolismo
3.
Neuron ; 110(19): 3139-3153.e6, 2022 Oct 05.
Artigo em Inglês | MEDLINE | ID: mdl-35998632

RESUMO

Of the neurotransmitters that influence neurogenesis, gamma-aminobutyric acid (GABA) plays an outstanding role, and GABA receptors support non-synaptic signaling in progenitors and migrating neurons. Here, we report that expression levels of diazepam binding inhibitor (DBI), an endozepine that modulates GABA signaling, regulate embryonic neurogenesis, affecting the long-term outcome regarding the number of neurons in the postnatal mouse brain. We demonstrate that DBI is highly expressed in radial glia and intermediate progenitor cells in the germinal zones of the embryonic mouse brain that give rise to excitatory and inhibitory cells. The mechanism by which DBI controls neurogenesis involves its action as a negative allosteric modulator of GABA-induced currents on progenitor cells that express GABAA receptors containing γ2 subunits. DBI's modulatory effect parallels that of GABAA-receptor-mediating signaling in these cells in the proliferative areas, reflecting the tight control that DBI exerts on embryonic neurogenesis.


Assuntos
Inibidor da Ligação a Diazepam , Receptores de GABA-A , Animais , Diazepam/farmacologia , Inibidor da Ligação a Diazepam/metabolismo , Desenvolvimento Embrionário , Camundongos , Neurogênese , Neurônios/fisiologia , Receptores de GABA-A/metabolismo , Ácido gama-Aminobutírico/metabolismo
4.
Cell Rep ; 33(2): 108256, 2020 10 13.
Artigo em Inglês | MEDLINE | ID: mdl-33053356

RESUMO

Angiogenesis and neurogenesis are tightly coupled during embryonic brain development. However, little is known about how these two processes interact. We show that nascent blood vessels actively contact dividing neural stem cells by endothelial filopodia in the ventricular zone (VZ) of the murine ventral telencephalon; this association is conserved in the human ventral VZ. Using mouse mutants with altered vascular filopodia density, we show that this interaction leads to prolonged cell cycle of apical neural progenitors (ANPs) and favors early neuronal differentiation. Interestingly, pharmacological experiments reveal that ANPs induce vascular filopodia formation by upregulating vascular endothelial growth factor (VEGF)-A in a cell-cycle-dependent manner. This mutual relationship between vascular filopodia and ANPs works as a self-regulatory system that senses ANP proliferation rates and rapidly adjusts neuronal production levels. Our findings indicate a function of vascular filopodia in fine-tuning neural stem cell behavior, which is the basis for proper brain development.


Assuntos
Células-Tronco Neurais/metabolismo , Neurogênese , Pseudópodes/metabolismo , Telencéfalo/irrigação sanguínea , Animais , Ciclo Celular , Diferenciação Celular , Proliferação de Células , Endotélio Vascular/metabolismo , Humanos , Camundongos Endogâmicos C57BL , Células-Tronco Neurais/citologia , Neurônios/citologia , Pseudópodes/ultraestrutura , Telencéfalo/ultraestrutura , Imagem com Lapso de Tempo , Regulação para Cima , Fator A de Crescimento do Endotélio Vascular/metabolismo
5.
Eur J Pharm Sci ; 101: 56-65, 2017 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-28153636

RESUMO

Quercetin (Q) is a flavonoid widely distributed in the plant kingdom and well-known for its ability to exert antioxidant, prooxidant and anticarcinogenic activities in several tumor cells. Furthermore, quercetin plays an important role both in the regulation of key elements in cellular signal transduction pathways related to apoptotic cell death, and in cell cycle progression. Several studies have reported of toxic effects of Q against glioma cell lines. In this study, the effects of Q and of some Q-derivatives (acyl esters and bromo-derivatives) on U373-MG and 9L glioma cell lines survival are analyzed. The 24-hour treatment of glioma cells with several concentrations of Q (25, 50 and 100µM) did not cause any cytotoxic effects, while the administration of Q-derivatives, such as acylated and brominated quercetin, caused a sharp increase in cell death. Among all tested derivatives, 3-O-decanoylquercetin 10 manifested the strongest cytotoxic effect at a concentration as low as 25µM both in U373-MG (ca. 40% viability after 24h) and in 9L cells (ca. 20% viability after 24h). The cytotoxic effects of the Q-derivatives 3 and 10-13 were proven to be satisfactorily selective for glioma cells. When Q-derivatives were in fact administered to mouse primary astroglial or human fibroblast cell cultures, a higher cell survival rate (~90-70% and 55-45%, respectively) was observed relative to that detected in glioma cells. These results prove that selective esterification and bromination of Q increase to a great extent the toxicity of this polyphenol against glioma cells, thereby providing a possible new tool for cyto-specific glioma therapy.


Assuntos
Apoptose/efeitos dos fármacos , Glioma/tratamento farmacológico , Quercetina/farmacologia , Animais , Antioxidantes/farmacologia , Linhagem Celular , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Humanos , Camundongos , Taxa de Sobrevida
6.
CNS Neurol Disord Drug Targets ; 15(4): 448-63, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26996174

RESUMO

Intellectual disability (ID) and autism are present in several neurodevelopmental disorders and are often associated in genetic syndromes, such as Fragile X and Rett syndromes. While most evidence indicates that a genetic component plays an important role in the aetiology of both autism and ID, a number of studies suggest that immunological dysfunctions may participate in the pathophysiology of these disorders. Brain-specific autoantibodies have been detected in the sera of many autistic children and autoimmune disorders are increased in families of children with autism. Furthermore, cytokine imbalance has been reported in children with autism. These results may reflect an inappropriate immune response to environmental factors, such as infectious or toxic exposure. The role of microglia as sensors of pre- and post-natal environmental stimuli and its involvement in the regulation of synaptic connectivity, maturation of brain circuitry and neurogenesis has recently emerged. An abnormal immune response during critical windows of development and consequent abnormal production of neuro-inflammatory mediators may have an impact on the function and structure of brain and can play a role in the pathogenesis of non syndromic autism. Recent evidence suggests an involvement of neuro-inflammation also in syndromic forms of autism and ID. Immune dysregulation has been found in children with Fragile X syndrome and an intrinsic microglia dysfunction has been recently reported in Rett syndrome. The present review summarizes the current literature suggesting that neuro-inflammatory mechanisms may contribute to the pathogenesis of different ID- and autism-associated disorders, thus representing common pathophysiological pathways and potential therapeutic targets.


Assuntos
Transtorno do Espectro Autista/etiologia , Citocinas/metabolismo , Doenças do Sistema Imunitário/complicações , Deficiência Intelectual/etiologia , Humanos , Doenças do Sistema Imunitário/etiologia , Microglia/metabolismo , Microglia/patologia
7.
Neuropharmacology ; 97: 329-37, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26116760

RESUMO

The central serotonin2B receptor (5-HT2BR) is currently considered as an interesting pharmacological target for improved treatment of drug addiction. In the present study, we assessed the effect of two selective 5-HT2BR antagonists, RS 127445 and LY 266097, on cocaine-induced hyperlocomotion and dopamine (DA) outflow in the nucleus accumbens (NAc) and the dorsal striatum of freely moving rats. The peripheral administration of RS 127445 (0.16 mg/kg, i.p.) or LY 266097 (0.63 mg/kg, i.p.) significantly reduced basal DA outflow in the NAc shell, but had no effect on cocaine (10 mg/kg, i.p.)-induced DA outflow in this brain region. Also, RS 127445 failed to modify both basal and cocaine-induced DA outflow in the NAc core and the dorsal striatum. Conversely, both 5-HT2BR antagonists reduced cocaine-induced hyperlocomotion. Furthermore, RS 127445 as well as the DA-R antagonist haloperidol (0.1 mg/kg, i.p.) reduced significantly the late-onset hyperlocomotion induced by the DA-R agonist quinpirole (0.5 mg/kg, s.c.). Altogether, these results demonstrate that 5-HT2BR blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical DA outflow. This interaction takes place downstream to DA neurons and could involve an action at the level of dorsostriatal and/or NAc DA transmission, in keeping with the importance of these brain regions in the behavioural responses of cocaine. Overall, this study affords additional knowledge into the regulatory control exerted by the 5-HT2BR on ascending DA pathways, and provides additional support to the proposed role of 5-HT2BRs as a new pharmacological target in drug addiction.


Assuntos
Cocaína/farmacologia , Corpo Estriado/efeitos dos fármacos , Inibidores da Captação de Dopamina/farmacologia , Dopamina/metabolismo , Atividade Motora/efeitos dos fármacos , Antagonistas do Receptor 5-HT2 de Serotonina/farmacologia , Animais , Corpo Estriado/metabolismo , Agonistas de Dopamina/farmacologia , Antagonistas de Dopamina/farmacologia , Haloperidol/farmacologia , Masculino , Atividade Motora/fisiologia , Pirimidinas/farmacologia , Quimpirol/farmacologia , Ratos Sprague-Dawley , Receptor 5-HT2B de Serotonina/metabolismo
8.
Nucleic Acids Res ; 35(2): 517-28, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17169985

RESUMO

Glucocorticoid-induced leucine zipper (GILZ) is a 137 amino acid protein, rapidly induced by treatment with glucocorticoids (GC), characterized by a leucine zipper (LZ) domain (76-97 amino acids), an N-terminal domain (1-75 amino acids) and a C-terminal PER domain (98-137 amino acids) rich in proline and glutamic acid residues. We have previously shown that GILZ binds to and inhibits NF-kappaB activity. In the present study we used a number of mutants with the aim of defining the GILZ molecular domains responsible for GILZ/p65NF-kappaB interaction. Results, obtained by in vitro and in vivo co-immunoprecipitation (Co-IP) and by transcriptional activity experiments, indicate that GILZ homo-dimerization, through the LZ domain, as well as the C-terminal PER domain, particularly the 121-123 amino acids, are both necessary for GILZ interaction with NF-kappaB, inhibition of transcriptional activity and of IL-2 synthesis.


Assuntos
Fator de Transcrição RelA/antagonistas & inibidores , Fatores de Transcrição/química , Sequência de Aminoácidos , Animais , Sítios de Ligação , Linhagem Celular , Dimerização , Humanos , Interleucina-2/biossíntese , Zíper de Leucina , Camundongos , Modelos Moleculares , Dados de Sequência Molecular , Mutação , NF-kappa B/antagonistas & inibidores , NF-kappa B/metabolismo , Estrutura Terciária de Proteína , Linfócitos T/imunologia , Fator de Transcrição RelA/metabolismo , Fatores de Transcrição/metabolismo , Transcrição Gênica
9.
Proc Natl Acad Sci U S A ; 103(20): 7823-8, 2006 May 16.
Artigo em Inglês | MEDLINE | ID: mdl-16672365

RESUMO

The FHIT gene has many hallmarks of a tumor-suppressor gene and is involved in a large variety of cancers. We treated A/J mice and (C57BL/6J x 129/SvJ)F1 (B6/129 F1) mice, either wild-type or FHIT+/-, with multiple doses of benzo[a]pyrene (B[a]P) by gavage. B[a]P caused a time-related increase of micronuclei in peripheral blood erythrocytes. Both A/J and B6/129 F1 mice, irrespective of their FHIT status, were sensitive to induction of forestomach tumors, whereas B[a]P induced glandular stomach hyperplasia and a high multiplicity of lung tumors in A/J mice only. Preneoplastic lesions of the uterus were more frequent in FHIT+/- mice. B6/129 F1 mice underwent spontaneous alopecia areata and hair bulb cell apoptosis, which were greatly accelerated either by FHIT heterozygosity or by B[a]P treatment, thus suggesting that FHIT plays a role in the pathogenesis of alopecia areata. The oral administration of either budesonide or N-acetyl-L-cysteine (NAC) inhibited the occurrence of this inflammatory skin disease. In addition, these agents prevented B[a]P-induced glandular stomach hyperplasia and decreased the size of both forestomach tumors and lung tumors in A/J mice. Budesonide also attenuated lung tumor multiplicity. In B6/129 F1 mice, NAC significantly decreased the proliferating cell nuclear antigen in lung tumors. Both budesonide and NAC inhibited B[a]P-induced forestomach tumors and preneoplastic lesions of the respiratory tract in B6/129 F1 mice. In conclusion, heterozygosity for FHIT affects susceptibility of mice to spontaneous alopecia areata and B[a]P-induced preneoplastic lesions of the uterus and does not alter responsiveness to budesonide and NAC.


Assuntos
Acetilcisteína/metabolismo , Hidrolases Anidrido Ácido/metabolismo , Alopecia em Áreas , Benzo(a)pireno/toxicidade , Budesonida/metabolismo , Proteínas de Neoplasias/metabolismo , Neoplasias , Acetilcisteína/uso terapêutico , Hidrolases Anidrido Ácido/genética , Alopecia em Áreas/induzido quimicamente , Alopecia em Áreas/prevenção & controle , Animais , Anti-Inflamatórios/metabolismo , Anti-Inflamatórios/uso terapêutico , Benzo(a)pireno/administração & dosagem , Benzo(a)pireno/metabolismo , Budesonida/uso terapêutico , Feminino , Genes Supressores de Tumor , Pulmão/patologia , Camundongos , Camundongos Endogâmicos , Proteínas de Neoplasias/genética , Neoplasias/induzido quimicamente , Neoplasias/prevenção & controle , Estômago/patologia
10.
Recenti Prog Med ; 97(1): 37-45, 2006 Jan.
Artigo em Italiano | MEDLINE | ID: mdl-16535929

RESUMO

There is growing evidence that reactive oxygen species (ROS) play a key role in the pathogenesis of primary open angle glaucoma (POAG). The occurrence of oxidative DNA damage in trabecular meshwork (TM) has been demonstrated by measuring the increase of 8-hydroxy-2'-deoxyguanosine, the most abundant DNA oxidative alteration, which is significantly increased in glaucoma-bearing subjects as compared with unaffected controls. Several lines of evidence support the hypothesis that ROS play a fundamental pathogenic role, including the following: (a) outflow resistance in the anterior chamber increases in the presence of high levels of hydrogen peroxide; (b) TM possesses abundant antioxidant activities; (c) significant increases in superoxide dismutase and glutathione peroxidase activities were detected in the aqueous humour of glaucoma patients; (d) hydrogen peroxide compromises TM integrity. The existence of a significant correlation between oxidative DNA damage and intraocular pressure in glaucoma patients has been reported. POAG patients appear to have a genetic predisposition rendering them susceptible to ROS-induced damage because of a more frequent deletion, as compared to controls, of the gene encoding for glutathione-S-transferase M1, a pivotal anti-oxidant activity. Furthermore, oxidative stress, occurring not only in TM but also in retinal cells, appears to be involved in the neuronal cell death that characterizes POAG. These considerations could bear relevance for POAG prevention and suggest that genetic analyses and the use of drugs or dietary measures attenuating the effects of ROS, if validated in future studies, could be useful tools contributing to the control of this disease.


Assuntos
Glaucoma de Ângulo Aberto , Antagonistas Adrenérgicos beta/uso terapêutico , Fatores Etários , Idoso , Humor Aquoso/metabolismo , Bloqueadores dos Canais de Cálcio/uso terapêutico , Dano ao DNA , Antagonistas de Aminoácidos Excitatórios/uso terapêutico , Predisposição Genética para Doença , Ginkgo biloba , Glaucoma de Ângulo Aberto/tratamento farmacológico , Glaucoma de Ângulo Aberto/epidemiologia , Glaucoma de Ângulo Aberto/etiologia , Glaucoma de Ângulo Aberto/genética , Glaucoma de Ângulo Aberto/metabolismo , Glaucoma de Ângulo Aberto/prevenção & controle , Glutationa Peroxidase , Humanos , Peróxido de Hidrogênio , Pressão Intraocular , Memantina/uso terapêutico , Pessoa de Meia-Idade , Estresse Oxidativo , Fitoterapia , Extratos Vegetais/uso terapêutico , Prevalência , Espécies Reativas de Oxigênio , Fatores de Risco , Superóxido Dismutase , Malha Trabecular/metabolismo
11.
Blood ; 101(2): 585-93, 2003 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-12393559

RESUMO

Glucocorticoid hormones (GCHs) regulate normal and neoplastic lymphocyte development by exerting antiproliferative and/or apoptotic effects. We have previously shown that dexamethasone (DEX)-activated thymocyte apoptosis requires a sequence of events including interaction with the glucocorticoid receptor (GR), phosphatidylinositol-specific phospholipase C (PI-PLC), and acidic sphingomyelinase (aSMase) activation. We analyzed the mechanisms of GCH-activated apoptosis by focusing on GR-associated Src kinase, cytochrome c release, and caspase-8, -9, and -3 activation. We show here that PI-PLC binds to GR-associated Src kinase, as indicated by coimmunoprecipitation experiments. Moreover, DEX treatment induces PI-PLC phosphorylation and activation. DEX-induced PI-PLC phosphorylation, activation, and apoptosis are inhibited by PP1, a Src kinase inhibitor, thus suggesting that Src-mediated PI-PLC activation is involved in DEX-induced apoptosis. Caspase-9, -8, and -3 activation and cytochrome c release can be detected 1 to 2 hours after DEX treatment. Caspase-9 inhibition does not counter cytochrome c release, caspase-8 and caspase-3 activation, and apoptosis. Caspase-8 inhibition counters cytochrome c release, caspase-9 and caspase-3 activation, and apoptosis, thus suggesting that caspase-8 inhibitor can directly inhibit caspase-9 and/or that DEX-induced caspase-8 activation is upstream to mitochondria and can regulate caspase-3 directly or through cytochrome c release and the consequent caspase-9/caspase-3 activation. DEX-induced caspase-8 activation, like ceramide-induced caspase-8 activation, correlates with the formation of Fas-associated death domain protein (FADD)/caspase-8 complex. Caspase-8 activation is countered by the inhibition of macromolecular synthesis and of Src kinase, PI-PLC, and aSMase activation, suggesting it is downstream in the DEX-activated apoptotic pathway of thymocytes.


Assuntos
Apoptose/efeitos dos fármacos , Caspases/metabolismo , Dexametasona/farmacologia , Glândula Tireoide/citologia , Quinases da Família src/fisiologia , Animais , Caspase 3 , Caspase 8 , Caspase 9 , Grupo dos Citocromos c/metabolismo , Ativação Enzimática , Inibidores Enzimáticos/farmacologia , Proteínas de Choque Térmico HSP90/metabolismo , Camundongos , Camundongos Endogâmicos C3H , Fosfatidilinositol Diacilglicerol-Liase , Fosfoinositídeo Fosfolipase C , Ligação Proteica , Receptores de Glucocorticoides/metabolismo , Glândula Tireoide/efeitos dos fármacos , Fosfolipases Tipo C/metabolismo , Quinases da Família src/metabolismo
12.
Mol Cell Biol ; 22(22): 7929-41, 2002 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12391160

RESUMO

Glucocorticoid-induced leucine zipper (GILZ) is a leucine zipper protein, whose expression is augmented by dexamethasone (DEX) treatment and downregulated by T-cell receptor (TCR) triggering. Stable expression of GILZ in T cells mimics some of the effects of glucocorticoid hormones (GCH) in GCH-mediated immunosuppressive and anti-inflammatory activity. In fact, GILZ overexpression inhibits TCR-activated NF-kappaB nuclear translocation, interleukin-2 production, FasL upregulation, and the consequent activation-induced apoptosis. We have investigated the molecular mechanism underlying GILZ-mediated regulation of T-cell activation by analyzing the effects of GILZ on the activity of mitogen-activated protein kinase (MAPK) family members, including Raf, MAPK/extracellular signal-regulated kinase (ERK) 1/2 (MEK-1/2), ERK-1/2, and c-Jun NH(2)-terminal protein kinase (JNK). Our results indicate that GILZ inhibited Raf-1 phosphorylation, which resulted in the suppression of both MEK/ERK-1/2 phosphorylation and AP-1-dependent transcription. We demonstrate that GILZ interacts in vitro and in vivo with endogenous Raf-1 and that Raf-1 coimmunoprecipitated with GILZ in murine thymocytes treated with DEX. Mapping of the binding domains and experiments with GILZ mutants showed that GILZ binds the region of Raf interacting with Ras through the NH(2)-terminal region. These data suggest that GILZ contributes, through protein-to-protein interaction with Raf-1 and the consequent inhibition of Raf-MEK-ERK activation, to regulating the MAPK pathway and to providing a further mechanism underlying GCH immunosuppression.


Assuntos
Sistema de Sinalização das MAP Quinases/fisiologia , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Proteínas Proto-Oncogênicas c-raf/metabolismo , Fatores de Transcrição/metabolismo , Ativação Transcricional , Sequência de Aminoácidos , Animais , Células Cultivadas , Proteínas de Ligação a DNA/química , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Dexametasona/farmacologia , Genes fos , Genes jun , Glucocorticoides/farmacologia , Interleucina-2/metabolismo , Zíper de Leucina , Ativação Linfocitária , Camundongos , Modelos Moleculares , Dados de Sequência Molecular , Fosforilação , Ligação Proteica , Estrutura Terciária de Proteína , Alinhamento de Sequência , Linfócitos T/citologia , Linfócitos T/metabolismo , Timo/citologia , Fator de Transcrição AP-1/metabolismo , Fatores de Transcrição/química , Fatores de Transcrição/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...